{"?xml":{"@version":"1.0"},"edm:RDF":{"@xmlns:dc":"http://purl.org/dc/elements/1.1/","@xmlns:edm":"http://www.europeana.eu/schemas/edm/","@xmlns:wgs84_pos":"http://www.w3.org/2003/01/geo/wgs84_pos","@xmlns:foaf":"http://xmlns.com/foaf/0.1/","@xmlns:rdaGr2":"http://rdvocab.info/ElementsGr2","@xmlns:oai":"http://www.openarchives.org/OAI/2.0/","@xmlns:owl":"http://www.w3.org/2002/07/owl#","@xmlns:rdf":"http://www.w3.org/1999/02/22-rdf-syntax-ns#","@xmlns:ore":"http://www.openarchives.org/ore/terms/","@xmlns:skos":"http://www.w3.org/2004/02/skos/core#","@xmlns:dcterms":"http://purl.org/dc/terms/","edm:WebResource":[{"@rdf:about":"http://www.dlib.si/stream/URN:NBN:SI:DOC-VWQJAEHH/f471ca4b-08be-4e33-99b2-7963b2ecadde/PDF","dcterms:extent":"150 KB"},{"@rdf:about":"http://www.dlib.si/stream/URN:NBN:SI:DOC-VWQJAEHH/babc4eaf-55cf-4d5c-8375-dcc54c14a2bf/TEXT","dcterms:extent":"54 KB"}],"edm:TimeSpan":{"@rdf:about":"1994-2025","edm:begin":{"@xml:lang":"en","#text":"1994"},"edm:end":{"@xml:lang":"en","#text":"2025"}},"edm:ProvidedCHO":{"@rdf:about":"URN:NBN:SI:DOC-VWQJAEHH","dcterms:isPartOf":[{"@rdf:resource":"https://www.dlib.si/details/URN:NBN:SI:spr-46R7GGHL"},{"@xml:lang":"sl","#text":"Medicinski razgledi"}],"dcterms:issued":"2006","dc:creator":["Ferjan, Mateja","Goličnik, Alenka"],"dc:format":[{"@xml:lang":"sl","#text":"številka:3"},{"@xml:lang":"sl","#text":"letnik:45"},{"@xml:lang":"sl","#text":"str. 221-236"}],"dc:identifier":["ISSN:0025-8121","COBISSID:22676953","URN:URN:NBN:SI:doc-VWQJAEHH"],"dc:language":"sl","dc:publisher":{"@xml:lang":"sl","#text":"Medicinski razgledi"},"dc:subject":[{"@xml:lang":"en","#text":"Age Factors"},{"@xml:lang":"en","#text":"Anemia"},{"@xml:lang":"sl","#text":"Anemija"},{"@xml:lang":"sl","#text":"ankete"},{"@xml:lang":"en","#text":"C-Reactive Protein"},{"@xml:lang":"sl","#text":"C-reaktivna beljakovina"},{"@xml:lang":"en","#text":"Diabetes Mellitus"},{"@xml:lang":"en","#text":"Heart Failure, Congestive"},{"@xml:lang":"en","#text":"Kidney Failure"},{"@xml:lang":"sl","#text":"Ledvična odpoved"},{"@xml:lang":"sl","#text":"Preživetje, analiza"},{"@xml:lang":"en","#text":"Questionnaires"},{"@xml:lang":"en","#text":"Sex Factors"},{"@xml:lang":"sl","#text":"Sladkorna bolezen"},{"@xml:lang":"sl","#text":"Spolni faktorji"},{"@xml:lang":"sl","#text":"Srce, odpoved kongestivna"},{"@xml:lang":"sl","#text":"srčno popuščanje"},{"@xml:lang":"sl","#text":"Starostni faktorji"},{"@xml:lang":"en","#text":"Survival Analysis"},{"@rdf:resource":"http://www.wikidata.org/entity/Q747810"}],"dcterms:temporal":{"@rdf:resource":"1994-2025"},"dc:title":{"@xml:lang":"sl","#text":"Vpliv aktivacije vnetnega odgovora na anemijo pri bolnikih s srčnim popuščanjem| Effect of activation of inflammatory response to anemia in patients with congesive heart failure|"},"dc:description":[{"@xml:lang":"sl","#text":"Anemia is a common comorbidity in patients with chronic heart failure. Compared to the general population, the prevalence of anemia is much higher among hears failure patients and is increasing with severity of the disease. Anemia therefore represents a strong independent prognostic f actor of adverseoutcome in these patients. Although recent data suggests that anemia inheart failure may be related to the activation of inflammatory response, rite evidence is- inconclusive. The aim of our study was to better define the patophysiologic background and prognostic factors in patients with heart failure and anemia, and to investigate the role of inflammatory response activation in this regard. A total of 95 patients with chronic heart failure and anemia defined as hemoglobin levels below 120 g/l were enrolled in this prospective study. Based on a standard questionnaire, data on morbidity and mortality were collected over a one-year period, including information on survival times and causes of death in patients who died in that period. Patients who died within 1 year had signiflcantly lower hemoglobin levels compared to those who survived (p<0.05). Contrary to our hypothesis, however, inflammatory activation was not associated with worse 1-year survival, and higher levels of CRP were not associated with lower hemoglobin levels. However, 1-year survival in our patient cohort was significantly affected by the presence of renal insufficiency (7C,% of patients with renal insufficiencyamong the expired vs. 41% in the remaining cohort, p < 0.05). Similarly, diabetes mellitus was more frequent among the expired patients titan in those who survived (p < 0.05). (Abstract truncated at 2000 characters)"},{"@xml:lang":"sl","#text":"Anemija je pogost pojav pri bolnikih s kroničnim srčnim popuščanjcm. Njena pogostnost je pri teh bolnikih večja kot v splošni populaciji in pomembno narašča z resnostjo bolezni cer predstavlja močan neodvisen napovedni dejavnikslabše prognoze. Vedno večja vloga v razvoju anemije pri bolnikih s srčnim popuščanjem se pripisuje aktivaciji vnetnega odgovora, ki dokazano spremlja srčno popuščanje. Namen naše raziskave je bil opredeliti vlogo aktiviranega vnetncga odgovora in posameznih drugih dejavnikov v razvoju anemije ter raziskati njihov vpliv na napoved pri bolniltih s kroničnim srčnimpopuščanjem in anemijo. V prospektivno raziskavo smo vključili 95 prostovoljcev s kroničnim srčnim popuščanjem in anemije, opredeljeno kot vrednosthemoglobina manj od 120 g/I. V sklopu rednega ambulantnega sledenja bolnikov smo pri preiskovancih izvedli anketiranje po vnaprej pripravljenem vprašalniku ter tako pridobili podatke o umrljivosti in obolevnosti preiskovancev v obdobju enega leta ter o času preživetja in vzroku smrti pri preiskovancih, M so v tem obdobju umrli. Umrli preiskovanci (n=37) so imeli v primerjavi s preživelimi (n= 58) hujšo stopnjo anemije (p < 0,05), ledvično popuščanje in sladkorna bolezen sia bila pri njih pogostejša (p < 0,05). V nasproiju z našo hipotezo vnetna aktivacija pri umrlih preiskovancih ni bila pogostejša, prav tako nismo našli povezave med povišanimi koncentracijami CRP in stopnjo anemije. Umrli preiskovanci so bili v povprečju starejši (p < 0,05), po deležu moških oz. žensk pa se niso razlikovali od preživelih. Starost ali spol nista vplivala na stopnjo anemije. Zdravljenje z zaviralci angiotenzinske konvertaze je bilo med umrlimi in preživelimi preiskovanci zastopano v primerljivih deležih. V multivariantni analizi sta bila prisotnostledvičnega popuščanja in sladkoxne bolezni edina neodvisna napovednadejavnika enoletnega preživetja preiskovancev (p < 0,05). (Izvleček skrajšan pri 2000 znakih)"}],"edm:type":"TEXT","dc:type":[{"@xml:lang":"sl","#text":"znanstveno časopisje"},{"@xml:lang":"en","#text":"journals"},{"@rdf:resource":"http://www.wikidata.org/entity/Q361785"}]},"ore:Aggregation":{"@rdf:about":"http://www.dlib.si/?URN=URN:NBN:SI:DOC-VWQJAEHH","edm:aggregatedCHO":{"@rdf:resource":"URN:NBN:SI:DOC-VWQJAEHH"},"edm:isShownBy":{"@rdf:resource":"http://www.dlib.si/stream/URN:NBN:SI:DOC-VWQJAEHH/f471ca4b-08be-4e33-99b2-7963b2ecadde/PDF"},"edm:rights":{"@rdf:resource":"http://rightsstatements.org/vocab/InC/1.0/"},"edm:provider":"Slovenian National E-content Aggregator","edm:intermediateProvider":{"@xml:lang":"en","#text":"National and University Library of Slovenia"},"edm:dataProvider":{"@xml:lang":"sl","#text":"Društvo Medicinski razgledi"},"edm:object":{"@rdf:resource":"http://www.dlib.si/streamdb/URN:NBN:SI:DOC-VWQJAEHH/maxi/edm"},"edm:isShownAt":{"@rdf:resource":"http://www.dlib.si/details/URN:NBN:SI:DOC-VWQJAEHH"}}}}